(Press-News.org) More than half of all premature babies born before the 28th week of pregnancy develop respiratory distress syndrome shortly after birth. As their lungs are not yet fully developed, they produce too little of the seemingly magical fluid that reduces surface tension in the lungs. As a result, some alveoli collapse – and the lungs are unable to get enough oxygen.
Lungs become more deformable
Until 40 years ago, this usually spelled death. But then, in the late 1980s, pediatricians developed a life-saving procedure: they extracted the fluid from animal lungs and injected it into the lungs of premature babies. "This works very well in newborns," says Jan Vermant, Professor of Soft Materials at ETH Zurich. "The fluid coats the entire surface, making the lungs more deformable or – with a more technical word - compliant."
But even in adults, lungs can fail. During the coronavirus pandemic, around 3,000 people in Switzerland developed acute respiratory distress syndrome. Injecting surface-active fluid from animal lungs into the lungs of adults, however, does not help. "This shows that it's not just about reducing surface tension," as Vermant states. "We believe that mechanical stresses within the fluid also play an important role."
In collaboration with scientists from Spain, Belgium and the USA, his research group harnessed sophisticated measurement techniques to investigate precisely how lung fluid behaves when it is stretched and recompressed in the laboratory. The fluid in our bodies is also subjected to similar movements when the lungs expand during inhalation and contract again during exhalation. The researchers have just published their findings in the journal Science Advances.
Explanation for the feeling of relief in the chest
In their experiments, the researchers simulated the movements of normal and particularly deep breaths – measuring the surface stress of the fluid in each case. "This surface stress influences how compliant the lungs are," explains Vermant. The more compliant the lungs are, the less resistance there is to expansion and contraction – and the easier it is to breathe.
With the help of their measuring instruments, the researchers found that surface stress decreases significantly after deep breaths. Apparently, there is a physical explanation for the feeling of relief experienced in the chest that often occurs after a deep sigh. The explanation starts from realizing that the thin film formed by the lung fluid on the surface of the lungs actually consists of several layers.
"Directly at the boundary with the air, there is a slightly stiffer surface layer. Underneath, there are several layers that should be softer than the surface layer," explains Maria Novaes-Silva, a doctoral student in Vermant's research group and first author of the study. As she has proven in experiments, this layering returns to the equilibrium configuration over time when the fluid does not move at all or moves only slightly during shallow breathing.
Reconstructing multilayered structures
A deep breath is needed from time to time to restore this ideal layering. Based on their analyses, the researchers have discovered that the pronounced stretching and compression of the pulmonary fluid causes the composition of the outer layer to change. " There is an enrichment of saturated lipids, this results in a more densely packed interface," says Novaes-Silva. Vermant adds: "This is a state outside of the boundaries of the thermodynamic equilibrium that can only be maintained through mechanical work."
It is also known from clinical practice that lung compliance gradually changes over time – and that breathing becomes increasingly difficult in connection with constant shallow breathing. The measurements in the laboratory therefore seems to reflect observations from the clinic. Novaes-Silva concludes: "These similarities are indications that we have captured real properties with our experimental setup."
Can the new insights gained by materials scientists also be used to derive expedient conclusions and insights for lung failure in adults? "A promising approach is to identify components that can artificially reconstruct multilayered structures," the researchers note in their technical article. In conversation, Vermant points to therapies involving foam that are currently being developed and researched in greater depth by other groups.
Reference
Novaes-Silva MC, Rodríguez-Hakim M, Thompson BR, Wagner NJ, Hermans E, Dupont LJ, Vermant J. How sighing regulates pulmonary surfactant structure and its role in breathing mechanics. Sci. Adv. (2025). DOI: 10.1126/sciadv.adx6034
END
Why deep sighs are actually good for us
2025-10-16
ELSE PRESS RELEASES FROM THIS DATE:
Unexpected discovery on Saturn's moon challenges our view on chemistry before life emerged
2025-10-16
Researchers at Chalmers University of Technology in Sweden and the US space agency NASA have made an unexpected discovery that challenges one of the basic rules of chemistry and provides new knowledge about Saturn’s enigmatic moon Titan. In its extremely cold environment, normally incompatible substances can still be mixed. This discovery broadens our understanding of chemistry before the emergence of life.
Scientists have long been interested in Saturn’s largest, orange-coloured moon as its evolution can teach us more about our own planet and the earliest chemical steps ...
The European project to reduce the number of animals used in experimentation, VICT3R, adds new partners and increases its budget to €30 million
2025-10-16
The VICT3R project is expanding its consortium by adding new beneficiaries and organisations to the network of contract research organisations (CROs) associated with the project. This expansion increases the project budget to €30 million and reinforces VICT3R's mission to transform the way safety is assessed in drug and chemical development, reducing reliance on laboratory animals.
New beneficiaries include leading industrial partners such as Servier Group and Zoetis Belgium SA. Servier is an independent international pharmaceutical group governed by a foundation, ...
New clinical trial to advance seizure monitoring and improve epilepsy diagnosis
2025-10-16
Thursday, 16 October 2025: A new clinical trial co-led by researchers at FutureNeuro and RCSI University of Medicine and Health Sciences is investigating how advanced brain monitoring could improve the diagnosis and management of epilepsy. Led in Ireland by consultant neurologists Professor Norman Delanty of RCSI and Beaumont Hospital and Dr Daniel Costello of Cork University Hospital (CUH) – two of the country’s busiest neurology departments – the trial involves multiple sites across Europe, with Irish patients making up more than ...
Sniffer dogs tested in real-world scenarios reveal need for wider access to explosives, study finds
2025-10-16
Dogs aren’t just our best friends, they’re also key allies in the fight against terrorism. Thousands of teams of explosive detection dogs and their handlers work 24/7 at airports, transit systems, cargo facilities, and public events around the globe to keep us safe. But canine detection is an art as well as a science: success depends not only on the skill of both dog and human, but also on their bond, and may vary with their physiological state and environmental conditions. Practices are often passed down informally between handlers, which can further hamper the consistency of performance across teams.
To remedy this, the American ...
Ex-smokers who relapse may simply be tired of the effort of not smoking
2025-10-16
The most reliable predictor of an ex-smoker’s relapse isn’t strong urges to smoke or low confidence in the ability to stay off tobacco – it’s weariness with the efforts to remain a non-smoker, according to a new study published today in Addiction. Ex-smokers appear to return to smoking most often because they’re exhausted from the constant vigilance needed to remain a non-smoker.
This effect is called psychological cessation fatigue, and its influence on ex-smokers is not affected by how long you’ve been an ex-smoker or whether you vape to reduce ...
A better way to monitor drug therapy at home
2025-10-16
Chemists at Université de Montréal have developed "signaling cascades" made with DNA molecules to report and quantify the concentration of various molecules in a drop of blood, all within 5 minutes. Their findings, validated by experiments on mice, are published today in the Journal of the American Chemical Society, may aid efforts to build point-of-care devices for monitoring and optimizing the treatment of various diseases.
This breakthrough was made by a research group led by UdeM chemistry professor Alexis Vallée-Bélisle. “One of the key factors ...
Rare earth engineering to mitigate corrosion challenges in seawater electrolysis
2025-10-16
As global demand for green hydrogen grows, scientists are exploring direct seawater electrolysis as a sustainable way to produce hydrogen without consuming scarce freshwater. Yet, seawater contains abundant chloride ions, which corrode electrodes and drastically shorten device lifetimes — a major barrier to commercialization.
A recent study by Shen et al., published in the Journal of the American Chemical Society (JACS, 2025), presents a promising breakthrough: a rare-earth oxide protection layer that shields seawater ...
MXene‑based wearable contact lenses: Integrating smart technology into vision care
2025-10-16
As wearable health technologies evolve, smart contact lenses (SCLs) are emerging as powerful platforms for non-invasive, real-time ocular diagnostics. Now, researchers from Istanbul Okan University and Istinye University, led by Prof. Ali Zarrabi and Dr. Siavash Iravani, have presented a comprehensive review on MXene-based smart contact lenses, highlighting their transformative potential in vision care and ophthalmic health monitoring. This work outlines how MXenes—2D transition metal carbides—can revolutionize contact lens functionality through biosensing, therapy, and user comfort.
Why MXene-Based Contact Lenses Matter
Multifunctionality: Enable real-time ...
Unlocking the power of gold: a breakthrough in green chemistry
2025-10-16
Acetaldehyde is a key chemical intermediate traditionally produced via the ethylene-based Wacker oxidation process, which is both costly and environmentally harmful. Selective oxidation of bioethanol to acetaldehyde offers a greener and more sustainable alternative, yet most reported catalysts struggle with the usual trade-off between activity and selectivity, typically yielding less than 90% acetaldehyde.
Notably, Liu and Hensen demonstrated a specific Au0-Cu+ synergy in the state-of-the-art Au/MgCuCr2O4 catalyst, achieving over 95% AC yield at 250oC with stable performance for over ...
Ru-Co single-atom alloy catalysts for efficient amination of alcohols
2025-10-16
Primary amines are extensively used in the manufacture of pharmaceuticals, agrochemicals, and material science. Among various reported methods to access primary amines, the direct amination of alcohols with ammonia is most promising and environmentally benign since alcohols can be derived from renewable biomass and the sole byproduct is water. While a large number of catalyst systems have been developed for alcohol amination, challenges remain to be addressed such as the low selectivity to primary amines at high alcohol ...